These three sub-sectors of healthcare got pummeled today. IMO, seems like a huge over-reaction. All this because of the GLP-1 drugs? Specifically, early stop to trial of Ozempic (a positive for the drug, as efficacy has been proven early).
I can understand investor concerns relating to direct renal care companies such as Davita $DVA and $BAX, seeing a 17% and 12% drop respectively today. But why are ...

Wood’s Ark Invest ETF and Berkshire Hathaway are often seen as prime examples of two very different investment styles — growth and value respectively. The reversal of their share prices reflects a jarring rotation between the two tribes in recent years.
Wood’s Ark Invest ETF and Berkshire Hathaway are often seen as prime examples of two very different investment styles — growth and value respectively. The reversal o...